BrainStorm Cell Therapeutics Inc (BCLI)

[jfk]

BCLI is doing its homework, and hopefully the technology works. But, a 3 year wait for a non-revenue biotech is the equivalent of a long slog through quicksand. The Canada and Israel options from what I heard are 'off the table'. No to compassionate use possibilities. I don't know what else these guys will have to sustain the share price. Further dilution will happen. I just don't know if it's going to be above or below the $2 mark. I don't have the nerve to sell, but I can understand those who are exiting, with the possibility of getting back in in the mid-$2's....it's headed there.